go back

Maryland rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $512,861 · 10th–90th $512,861–$588,8440%50%90th$512,861Professionalmedian $588,844 · 10th–90th $588,844–$707,9460%50%90th$588,844$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$512,861.38 / $512,861.38 / $588,843.66
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $645,654.23
Kaiser Permanente
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$501,187.23 / $588,843.66 / $616,595.00
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $660,693.45 / $794,328.23
Wellpoint
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66